Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Executive Chair Share Purchase

7 Apr 2025 12:05

RNS Number : 9498D
Science Group PLC
07 April 2025
 

 

7 April 2025

 

Science Group plc

(the "Company" or "Science Group")

 

Executive Chair Share Purchase

 

Science Group plc (AIM:SAG) announces that it has been notified by Martyn Ratcliffe, Executive Chair of the Company that on 7 April 2025 he purchased 10,000 ordinary shares of 1p each in the Company at a price of 410 pence per share for his SIPP.

 

Following this purchase, Martyn Ratcliffe has an interest in 9,492,080 ordinary shares in the Company (being approximately 21.27% of the issued share capital excluding treasury shares). This holding comprises 9,412,080 shares held directly and 80,000 shares held in his SIPP.

 

All other Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced. 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Martyn Ratcliffe

 

Reason for the notification

a)

Position/status: Executive Chair

b)

Initial notification/Amendment: Initial notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Science Group plc

b)

LEI: 2138009OJQT79BDB3E93

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B39GTJ17

b)

Nature of the transaction: Purchase of shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

410p

10,000

d)

Aggregated information:

· Aggregated volume: 10,000

· Price: £41,000

e)

Date of the transaction: 2025-04-07

f)

Place of the transaction: AIMX

 

 

- Ends -

 

 

For further information:

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

Liberum Capital Limited (Joint Broker)

Max Jones, John More

Tel: +44 (0) 20 3100 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGGDMNMGKZM
Date   Source Headline
20th Mar 20267:02 amRNSHolding(s) in Company
20th Mar 20267:01 amRNSChair Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:01 amRNSAudited Results for Year Ended 31 December 2025
17th Mar 20267:01 amRNSAudited Results for Year Ended 31 December 2025
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20262:15 pmRNSNotice of Preliminary Results
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:01 amRNSFY25 Update and FY26 Share Buy-Back Programme
13th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.